Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro.
Remifentanil-induced secondary hyperalgesia has been demonstrated in both animal experiments and clinical trials. Enhancement of N-methyl-D-aspartate (NMDA) receptor trafficking as well as protein kinase C (PKC) and calmodulin-dependent protein kinase II (CaMKII) have been reported to be involved in...
Main Authors: | Yuan Yuan, Zhe Sun, Yi Chen, Yuxin Zheng, Ke-Liang Xie, Ying He, Zhifen Wang, Guo-Lin Wang, Yong-Hao Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5300256?pdf=render |
Similar Items
-
PLGA-Curcumin Attenuates Opioid-Induced Hyperalgesia and Inhibits Spinal CaMKIIα.
by: Xiaoyu Hu, et al.
Published: (2016-01-01) -
TRPV1 channel contributes to remifentanil-induced postoperative hyperalgesia via regulation of NMDA receptor trafficking in dorsal root ganglion
by: Song C, et al.
Published: (2019-02-01) -
Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia
by: Cheol Lee, et al.
Published: (2013-04-01) -
NMDA receptor-mediated CaMKII/ERK activation contributes to renal fibrosis
by: Jingyi Zhou, et al.
Published: (2020-09-01) -
Simvastatin Enhances Activity and Trafficking of α7 Nicotinic Acetylcholine Receptor in Hippocampal Neurons Through PKC and CaMKII Signaling Pathways
by: Tingting Chen, et al.
Published: (2018-04-01)